![Cynthia Sirard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 31 075 $ al 31/05/2026
Cynthia Sirard is currently Chief Medical Officer at Compass Therapeutics, Inc. since 2026.
Formerly, Dr. Sirard was Chief Medical Officer at Cypherpunk Technologies, Inc. from 2020 to 2025 and Medical Director at PAREXEL International Corp.
from 2003 to 2005.
Education includes undergraduate studies at the University of Massachusetts and a doctorate from Chicago Medical School.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 20/04/2026 | 27.500 ( 0,03 % ) | 31 075 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| COMPASS THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/01/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| CYPHERPUNK TECHNOLOGIES INC. | Director Técnico/Científico/I+D | 31/07/2025 |
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | 01/01/2005 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chicago Medical School
 Chicago Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leap Therapeutics, Inc.
 Leap Therapeutics, Inc. BiotechnologyHealth Technology Engages in clinical stage immuno-oncology | Health Technology |
Compass Therapeutics, Inc.
 Compass Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology biopharmaceutical company that develops antibody based therapeutics to treat multiple human diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
